KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Novavax (NVAX) Receivables - Net (2016 - 2025)

Novavax (NVAX) has 14 years of Receivables - Net data on record, last reported at $114.1 million in Q4 2025.

  • For Q4 2025, Receivables - Net rose 10.9% year-over-year to $114.1 million; the TTM value through Dec 2025 reached $114.1 million, up 10.9%, while the annual FY2025 figure was $114.1 million, 5.39% up from the prior year.
  • Receivables - Net reached $114.1 million in Q4 2025 per NVAX's latest filing, up from $28.9 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $478.2 million in Q1 2022 and bottomed at $28.9 million in Q3 2025.
  • Average Receivables - Net over 5 years is $158.3 million, with a median of $107.3 million recorded in 2022.
  • Peak YoY movement for Receivables - Net: soared 740.37% in 2022, then tumbled 90.12% in 2024.
  • A 5-year view of Receivables - Net shows it stood at $455.0 million in 2021, then plummeted by 78.85% to $96.2 million in 2022, then soared by 216.93% to $304.9 million in 2023, then crashed by 66.25% to $102.9 million in 2024, then grew by 10.9% to $114.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $114.1 million in Q4 2025, $28.9 million in Q3 2025, and $221.1 million in Q2 2025.